Vitrolife acquiring OCTAX and MTG, jointly holding a world-leading position in laser technology for IVF
Vitrolife AB (publ) has completed the acquisition of 100% of the shares in OCTAX Microscience GmbH “OCTAX” and MTG Medical Technology Vertriebs-GmbH “MTG”. Vitrolife thereby strengthens its market position and broadens the product portfolio within a growth segment of IVF.Profitable growth companiesOCTAX is the developer and producer of the world-leading OCTAX Laser and Imaging Systems. MTG is the exclusive global distributor of OCTAX and acts as a distributor in Germany, Austria and Switzerland for IVF products from other manufacturers as well. Furthermore, MTG develops and markets a